Skip to main content

Nerve Regeneration Market Assessment and Professional Application Scope Shared In Detailed Report, Forecast 2023

Nerve Regeneration Market Research by Product, (Neurostimulation & Neuromodulation Devices and Biomaterials), by Application, (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and others), by End User (Hospitals & Clinics, Ambulatory Surgery Centers and others) and Regional Size, Growth Analysis, Technology Enhancements and Trends – Forecast till 2024.
Neuroregeneration or nerve regeneration refers to the process of repair and regrowth of injured nerve tissues, cells, and cell products. Investments in research and development are likely to boost the market demand significantly. For instance, Polyganics has established a new unit at the Zernike Campus, Netherlands for expanding their R&D unit.
The Global Nerve Regeneration Market Size is Expected to register 11.34% CAGR To reach USD 12695.25 Million by 2024.
Surgeries to embed neurostimulation devices, as well as ongoing developments of a brain computer interface, can influence the market in the coming years. Advances in neuroimaging and neurostimulation which can provide relief to patients, can drive the market demand significantly.
Market Key Players
Collaborations, product launches, and technological breakthroughs are certain strategies that can influence players in the market.
Boston Scientific Corporation, Medtronic, Integra LifeSciences, Abbott, Axogen Corporation, LivaNova PLC, Nuvectra Corporation, Stryker Corporation, Polyganics, and NeuroPace are key players in the global nerve regeneration market.
Primary end users of the global nerve regeneration market include hospitals & clinics, ambulatory surgery centers, and others.
13 LIST OF FIGURES
FIGURE 1 GLOBAL NERVE REGENERATION MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET
FIGURE 5 VALUE CHAIN: GLOBAL NERVE REGENERATION MARKET
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET
FIGURE 7 GLOBAL NERVE REGENERATION MARKET, BY PRODUCT, 2018 & 2024 (USD MILLION)
FIGURE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2018 & 2024 (USD MILLION)
FIGURE 9 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2018 & 2024 (USD MILLION)
FIGURE 10 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2018 & 2024 (USD MILLION)
FIGURE 11 AMERICAS: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%)
FIGURE 12 EUROPE: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%)
FIGURE 13 ASIA–PACIFIC: NERVE REGENERATION MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 14 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%)
FIGURE 15 GLOBAL NERVE REGENERATION MARKET COMPANY SHARE ANALYSIS, 2018 (%)
Continued…
Browse Complete Premium Report Details of “Nerve Regeneration Market Research Report – Global Forecast till 2024” at: https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202
MRFR segments the global nerve regeneration market on the basis of regions into Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA).
Market Segmentation
The global nerve regeneration market has been segmented on the basis of product, application, and end user.
Based on product, the market has been segregated into neurostimulation & neuromodulation devices and biomaterials. On the basis of neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Internal neurostimulation devices has been further segmented into vagus nerve stimulation, spinal cord stimulation, sacral nerve stimulation, deep brain stimulation, and gastric electrical stimulation. External neurostimulation devices cover transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Nerve conduits, nerve wraps, nerve protectors, and nerve connectors are segments encompassed within the biomaterials segment. Among them, the neurostimulation and neuromodulation devices segment was valued at USD 4,764.96 million in 2018. Large number of movement disorders and need for such tools for their treatment can drive the segment growth.
Major market applications include neurostimulation and neuromodulation surgeries, nerve grafting, stem cell therapy, direct nerve repair/neurorrhaphy, and others. Neurostimulation and neuromodulation surgeries have been further segmented into internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting encompasses autografts, allografts, and xenografts.
For instance, NervGen Pharma recently decided to collaborate with Case Western Reserve University for rapidly bringing to market a new technology capable of treating patients with spinal cord injury. The use of proprietary agents termed as ISP can be used to impede the signals of protein tyrosine phosphatase (PTP), a key component that inhibits nerve regeneration.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...
3 comments
Read more

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...
Post a Comment
Read more

North America wheelchair transportation Market by Leading Key Players, Product Applications in that Regional Forecast 2028

  North America Active Wheelchair Market Overview: The North America Active Wheelchair Market size is expected to grow at more than 7.7% CAGR to reach above USD 970 million by 2028 from a little above USD 502 million in 2019. Explore 27 market data Tables spread through nearly 57 Pages and in-depth analysis on “North AmericaActive Wheelchair market By Type (Manual, Powered), Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury) and by Country (US, Canada, Mexico), Regional Trends and Forecast from 2019 to 2028. Global North America active  wheelchair transportation   Market research provides a detailed Analytical Insights of global Market size, regional and country-level scope, segmentation wise growth, global share, Competition Scenario, sales analysis, impact global Market players on domestic players, value chain optimization, tra...
Post a Comment
Read more